Xlife Sciences AG
Develops and commercializes early-stage life sciences research projects.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
Description
Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-12 08:30 |
Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfo…
|
English | 7.3 KB | ||
| 2025-12-12 01:00 |
Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfo…
|
English | 9.7 KB | ||
| 2025-12-12 01:00 |
Preisgekrönter Leber-PET-Tracer unterstreicht die Stärke unseres Innovationspor…
|
German | 10.1 KB | ||
| 2025-12-08 07:00 |
Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner a…
|
English | 6.9 KB | ||
| 2025-12-08 01:00 |
Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner a…
|
English | 9.2 KB | ||
| 2025-12-08 01:00 |
Xlife Sciences AG verkündet Exit von 12 Projektgesellschaften an Grupo Landstei…
|
German | 13.2 KB | ||
| 2025-12-01 07:00 |
Xlife Sciences AG Delivers Breakthrough in Early Alzheimers Detection, Unlockin…
|
English | 3.7 KB | ||
| 2025-12-01 01:00 |
Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocki…
|
English | 5.8 KB | ||
| 2025-12-01 01:00 |
Xlife Sciences AG erzielt Durchbruch bei der Früherkennung von Alzheimer und er…
|
German | 9.0 KB | ||
| 2025-11-28 13:10 |
Xlife Sciences AG Provides Update on VERAXA Biotech AGs NASDAQ Listing Process …
|
English | 9.0 KB | ||
| 2025-11-28 01:00 |
Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process…
|
English | 11.7 KB | ||
| 2025-11-28 01:00 |
Xlife Sciences AG gibt ein Update zum Stand des NASDAQ-Listing-Prozesses der VE…
|
German | 12.0 KB | ||
| 2025-10-16 07:00 |
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a St…
|
English | 8.0 KB | ||
| 2025-10-16 02:00 |
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a St…
|
English | 10.2 KB | ||
| 2025-10-16 02:00 |
Xlife Sciences AG veröffentlicht ESG-Bericht 2024: Nachhaltige Wertschöpfung al…
|
German | 9.8 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
